FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1511344849> ?p ?o ?g. }

• W1511344849 endingPage "28275" @default.
• W1511344849 startingPage "28268" @default.
• W1511344849 abstract "The purpose of the present study was to develop an approach to directly monitor structural changes in a G protein-coupled receptor in response to drug binding. Purified human β2 adrenergic receptor was covalently labeled with the cysteine-reactive, fluorescent probe N,N′-dimethyl-N-(iodoacetyl)-N′ - (7 - nitrobenz -2 - oxa -1,3diazol-4-yl)ethylenediamine (IANBD). IANBD is characterized by a fluorescence which is highly sensitive to the polarity of its environment. We found that the full agonist, isoproterenol, elicited a stereoselective and dose-dependent decrease in fluorescence from IANBD-labeled β2 receptor. The change in fluorescence could be plotted against the concentration of isoproterenol as a simple hyperbolic binding isotherm demonstrating interaction with a single binding site in the receptor. The ability of several adrenergic antagonists to reverse the response confirmed that this binding site is identical to the well described binding site in the β2 receptor. Comparison of the response to isoproterenol with a series of adrenergic agonists, having different biological efficacies, revealed a linear correlation between biological efficacy and the change in fluorescence. This suggests that the agonist-mediated decrease in fluorescence from IANBD-labeled β2 receptor is due to the same conformational change as involved in receptor activation and G protein coupling. In contrast to agonists, negative antagonists induced a small but significant increase in base-line fluorescence. Despite the small amplitude of this response, it supports the notion that antagonists by themselves may alter receptor structure. In conclusion, our data provide the first direct evidence for ligand-specific conformational changes occurring in a G protein-coupled receptor. Furthermore, the data demonstrate the potential of fluorescence spectroscopy as a tool for further delineating the molecular mechanisms of drug action at G protein-coupled receptors. The purpose of the present study was to develop an approach to directly monitor structural changes in a G protein-coupled receptor in response to drug binding. Purified human β2 adrenergic receptor was covalently labeled with the cysteine-reactive, fluorescent probe N,N′-dimethyl-N-(iodoacetyl)-N′ - (7 - nitrobenz -2 - oxa -1,3diazol-4-yl)ethylenediamine (IANBD). IANBD is characterized by a fluorescence which is highly sensitive to the polarity of its environment. We found that the full agonist, isoproterenol, elicited a stereoselective and dose-dependent decrease in fluorescence from IANBD-labeled β2 receptor. The change in fluorescence could be plotted against the concentration of isoproterenol as a simple hyperbolic binding isotherm demonstrating interaction with a single binding site in the receptor. The ability of several adrenergic antagonists to reverse the response confirmed that this binding site is identical to the well described binding site in the β2 receptor. Comparison of the response to isoproterenol with a series of adrenergic agonists, having different biological efficacies, revealed a linear correlation between biological efficacy and the change in fluorescence. This suggests that the agonist-mediated decrease in fluorescence from IANBD-labeled β2 receptor is due to the same conformational change as involved in receptor activation and G protein coupling. In contrast to agonists, negative antagonists induced a small but significant increase in base-line fluorescence. Despite the small amplitude of this response, it supports the notion that antagonists by themselves may alter receptor structure. In conclusion, our data provide the first direct evidence for ligand-specific conformational changes occurring in a G protein-coupled receptor. Furthermore, the data demonstrate the potential of fluorescence spectroscopy as a tool for further delineating the molecular mechanisms of drug action at G protein-coupled receptors." @default.
• W1511344849 created "2016-06-24" @default.
• W1511344849 creator A5070435563 @default.
• W1511344849 creator A5079682203 @default.
• W1511344849 creator A5084080774 @default.
• W1511344849 date "1995-11-01" @default.
• W1511344849 modified "2023-10-18" @default.
• W1511344849 title "Fluorescent Labeling of Purified β2 Adrenergic Receptor" @default.
• W1511344849 cites W1445935732 @default.
• W1511344849 cites W1489775551 @default.
• W1511344849 cites W1513811643 @default.
• W1511344849 cites W1530312409 @default.
• W1511344849 cites W1536524213 @default.
• W1511344849 cites W1600615773 @default.
• W1511344849 cites W1605393199 @default.
• W1511344849 cites W1880336884 @default.
• W1511344849 cites W1964191104 @default.
• W1511344849 cites W1980702943 @default.
• W1511344849 cites W1981047025 @default.
• W1511344849 cites W1990243260 @default.
• W1511344849 cites W2007199009 @default.
• W1511344849 cites W2018866549 @default.
• W1511344849 cites W2022772025 @default.
• W1511344849 cites W2036379629 @default.
• W1511344849 cites W2038657745 @default.
• W1511344849 cites W2062778364 @default.
• W1511344849 cites W2062912306 @default.
• W1511344849 cites W2065812771 @default.
• W1511344849 cites W2069828003 @default.
• W1511344849 cites W2076983520 @default.
• W1511344849 cites W2091744790 @default.
• W1511344849 cites W2100837269 @default.
• W1511344849 cites W2172060077 @default.
• W1511344849 cites W2337060274 @default.
• W1511344849 cites W986271750 @default.
• W1511344849 doi "https://doi.org/10.1074/jbc.270.47.28268" @default.
• W1511344849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7499324" @default.
• W1511344849 hasPublicationYear "1995" @default.
• W1511344849 type Work @default.
• W1511344849 sameAs 1511344849 @default.
• W1511344849 citedByCount "267" @default.
• W1511344849 countsByYear W15113448492012 @default.
• W1511344849 countsByYear W15113448492013 @default.
• W1511344849 countsByYear W15113448492014 @default.
• W1511344849 countsByYear W15113448492015 @default.
• W1511344849 countsByYear W15113448492016 @default.
• W1511344849 countsByYear W15113448492017 @default.
• W1511344849 countsByYear W15113448492018 @default.
• W1511344849 countsByYear W15113448492019 @default.
• W1511344849 countsByYear W15113448492020 @default.
• W1511344849 countsByYear W15113448492021 @default.
• W1511344849 countsByYear W15113448492022 @default.
• W1511344849 countsByYear W15113448492023 @default.
• W1511344849 crossrefType "journal-article" @default.
• W1511344849 hasAuthorship W1511344849A5070435563 @default.
• W1511344849 hasAuthorship W1511344849A5079682203 @default.
• W1511344849 hasAuthorship W1511344849A5084080774 @default.
• W1511344849 hasBestOaLocation W15113448491 @default.
• W1511344849 hasConcept C107824862 @default.
• W1511344849 hasConcept C116569031 @default.
• W1511344849 hasConcept C121332964 @default.
• W1511344849 hasConcept C12554922 @default.
• W1511344849 hasConcept C170493617 @default.
• W1511344849 hasConcept C185592680 @default.
• W1511344849 hasConcept C2777339483 @default.
• W1511344849 hasConcept C2778938600 @default.
• W1511344849 hasConcept C55493867 @default.
• W1511344849 hasConcept C58732023 @default.
• W1511344849 hasConcept C62520636 @default.
• W1511344849 hasConcept C86803240 @default.
• W1511344849 hasConcept C91881484 @default.
• W1511344849 hasConceptScore W1511344849C107824862 @default.
• W1511344849 hasConceptScore W1511344849C116569031 @default.
• W1511344849 hasConceptScore W1511344849C121332964 @default.
• W1511344849 hasConceptScore W1511344849C12554922 @default.
• W1511344849 hasConceptScore W1511344849C170493617 @default.
• W1511344849 hasConceptScore W1511344849C185592680 @default.
• W1511344849 hasConceptScore W1511344849C2777339483 @default.
• W1511344849 hasConceptScore W1511344849C2778938600 @default.
• W1511344849 hasConceptScore W1511344849C55493867 @default.
• W1511344849 hasConceptScore W1511344849C58732023 @default.
• W1511344849 hasConceptScore W1511344849C62520636 @default.
• W1511344849 hasConceptScore W1511344849C86803240 @default.
• W1511344849 hasConceptScore W1511344849C91881484 @default.
• W1511344849 hasIssue "47" @default.
• W1511344849 hasLocation W15113448491 @default.
• W1511344849 hasOpenAccess W1511344849 @default.
• W1511344849 hasPrimaryLocation W15113448491 @default.
• W1511344849 hasRelatedWork W1498878647 @default.
• W1511344849 hasRelatedWork W1592264250 @default.
• W1511344849 hasRelatedWork W1805867622 @default.
• W1511344849 hasRelatedWork W2016553169 @default.
• W1511344849 hasRelatedWork W2071094466 @default.
• W1511344849 hasRelatedWork W2077716275 @default.
• W1511344849 hasRelatedWork W2269717305 @default.
• W1511344849 hasRelatedWork W3023520737 @default.
• W1511344849 hasRelatedWork W3045812983 @default.
• W1511344849 hasRelatedWork W3136719764 @default.

• next